Again, Why would Innovus apply for a trademark (s
Post# of 405
(Total Views: 1181)
Posted On: 03/19/2017 2:32:29 PM
Again, Why would Innovus apply for a trademark (spend the money) if the FlutiCare name wasn't already approved by the FDA ?
The FDA HAS to be ok with the naming of the product as that is part of their review process. To me, and others can surely weigh in, we are in the final stages here. If no opposition to the name/trademark comes - I think this is the absolute last piece before official FDA approval hits. In other words, it is in my belief that once we get the trademark - a PR WILL happen. I don't exactly know how much time someone could have to oppose this but my guess would be 30 days from when the examiner approved it. Remember, Novalere, went through this process before too but when they sold the rights to Innovus, they (INNV) now started up the trademark review last December. FDA has had to be in touch with them, which makes sense for the Dr. to be so confident ! He wants to hit the ground running and is getting the cash in place IMO.
How much you want to bet that the net of $3.3M will go to a new product launch (Xyralid) AND getting Sensum and Zestra distributed to those 28 EU countries ? Then, when the warrants get exercised, that money will be solely used for Fluti distribution in 2nd half of 2017 as PPS will skyrocket, once approved. 50M warrants x .15 = ~7.5M
Furthermore, IMO, the buyer(s) of this recent offering probably PROMISED to exercise the warrants ASAP which would give INNV the immediate cash. To do this, they negotiated the same price on the 1 and 5 yr warrants at the low 15 cents. DR D knows Fluti makes them profitable sooner rather than later...HE NEEDS THE FUNDS TO GET THE PRODUCT(S) DISTRIBUTED
The FDA HAS to be ok with the naming of the product as that is part of their review process. To me, and others can surely weigh in, we are in the final stages here. If no opposition to the name/trademark comes - I think this is the absolute last piece before official FDA approval hits. In other words, it is in my belief that once we get the trademark - a PR WILL happen. I don't exactly know how much time someone could have to oppose this but my guess would be 30 days from when the examiner approved it. Remember, Novalere, went through this process before too but when they sold the rights to Innovus, they (INNV) now started up the trademark review last December. FDA has had to be in touch with them, which makes sense for the Dr. to be so confident ! He wants to hit the ground running and is getting the cash in place IMO.
How much you want to bet that the net of $3.3M will go to a new product launch (Xyralid) AND getting Sensum and Zestra distributed to those 28 EU countries ? Then, when the warrants get exercised, that money will be solely used for Fluti distribution in 2nd half of 2017 as PPS will skyrocket, once approved. 50M warrants x .15 = ~7.5M
Furthermore, IMO, the buyer(s) of this recent offering probably PROMISED to exercise the warrants ASAP which would give INNV the immediate cash. To do this, they negotiated the same price on the 1 and 5 yr warrants at the low 15 cents. DR D knows Fluti makes them profitable sooner rather than later...HE NEEDS THE FUNDS TO GET THE PRODUCT(S) DISTRIBUTED
(1)
(0)Innovus Pharmaceuticals Inc. (INNV) Stock Research Links
Scroll down for more posts ▼